Cargando…
Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone
STUDY QUESTION: Does treatment of constitutional delay of growth and puberty (CDGP) in boys with aromatase inhibitor letrozole (Lz) or conventional low-dose testosterone (T) have differing effects on developing seminiferous epithelium? SUMMARY ANSWER: Anti-Müllerian hormone (AMH) declined similarly...
Autores principales: | Kohva, E, Varimo, T, Huopio, H, Tenhola, S, Voutilainen, R, Toppari, J, Miettinen, P J, Vaaralahti, K, Viinamäki, J, Backman, J T, Hero, M, Raivio, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048712/ https://www.ncbi.nlm.nih.gov/pubmed/31958337 http://dx.doi.org/10.1093/humrep/dez231 |
Ejemplares similares
-
Health-related quality of life in boys with constitutional delay of growth and puberty
por: Kariola, Laura, et al.
Publicado: (2022) -
Circulating Liver-enriched Antimicrobial Peptide-2 Decreases During Male Puberty
por: Varimo, Tero, et al.
Publicado: (2022) -
Recombinant Human FSH Treatment Outcomes in Five Boys With Severe Congenital Hypogonadotropic Hypogonadism
por: Kohva, Ella, et al.
Publicado: (2018) -
Letrozole Monotherapy in Pre- and Early-Pubertal Boys Does Not Increase Adult Height
por: Varimo, Tero, et al.
Publicado: (2019) -
Treatment of gonadotropin deficiency during the first year of life: long-term observation and outcome in five boys
por: Kohva, Ella, et al.
Publicado: (2019)